当前位置:药药网 / 数据中心 / 儿科研究特征电子表格
DENGVAXIA
通用名称
DENGUE Tetravalent Vaccine, Live
儿科标签批准日期
2019/5/1 0:00:00
特定指示/秒
Indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 9 through 16 years of age with laboratory-confirmed previous dengue infection and living in endemic areas.
标签更改摘要
See Package Insert for new information on biologics